• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜间皮瘤:综述

Peritoneal mesothelioma: a review.

作者信息

Bridda Alessio, Padoan Ilaria, Mencarelli Roberto, Frego Mauro

机构信息

Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128 Padova, Italy.

出版信息

MedGenMed. 2007 May 10;9(2):32.

PMID:17955087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1994863/
Abstract

Malignant peritoneal mesothelioma (MPM) is a rare aggressive tumor of the peritoneum, regarded as a universally fatal disease. It is poorly described and the knowledge of its natural history is very limited. Occupational and environmental asbestos exposure still remains a public health problem around the world. The incidence has increased in the past 2 decades. Only 20% to 33% of all mesotheliomas arise from the peritoneum itself; the pleura is the most common site of origin.

摘要

恶性腹膜间皮瘤(MPM)是一种罕见的侵袭性腹膜肿瘤,被视为一种普遍致命的疾病。对其描述甚少,对其自然史的了解也非常有限。职业和环境中的石棉暴露在全球范围内仍然是一个公共卫生问题。在过去20年中,其发病率有所上升。所有间皮瘤中只有20%至33%起源于腹膜本身;胸膜是最常见的起源部位。

相似文献

1
Peritoneal mesothelioma: a review.腹膜间皮瘤:综述
MedGenMed. 2007 May 10;9(2):32.
2
[Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis].[恶性腹膜间皮瘤肿瘤。演变、治疗、预后]
Rev Med Chir Soc Med Nat Iasi. 2007 Jul-Sep;111(3):673-7.
3
Treatment of Malignant Peritoneal Mesothelioma.恶性腹膜间皮瘤的治疗
Klin Onkol. 2019 Fall;32(5):333-337. doi: 10.14735/amko2019333.
4
Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium.非胸膜间皮瘤:腹膜、鞘膜和心包间皮瘤。
Hematol Oncol Clin North Am. 2005 Dec;19(6):1067-87, vi. doi: 10.1016/j.hoc.2005.09.005.
5
Advances in malignant peritoneal mesothelioma.恶性腹膜间皮瘤的进展
Int J Colorectal Dis. 2015 Jan;30(1):1-10. doi: 10.1007/s00384-014-2029-1. Epub 2014 Oct 21.
6
[A case of peritoneal mesothelioma with direct invasion to gastric mucosa].一例直接侵犯胃黏膜的腹膜间皮瘤
Korean J Gastroenterol. 2010 Dec;56(6):377-81. doi: 10.4166/kjg.2010.56.6.377.
7
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.恶性胸膜和腹膜间皮瘤的发病率、治疗和生存情况:一项基于人群的研究。
Thorax. 2022 Dec;77(12):1260-1267. doi: 10.1136/thoraxjnl-2021-217709. Epub 2022 Feb 11.
8
['Malignant peritoneal mesothelioma': a condition difficult to diagnose].“恶性腹膜间皮瘤”:一种难以诊断的病症
Ned Tijdschr Geneeskd. 2012;156(15):A4269.
9
[Diffuse malignant peritoneal mesothelioma: apropos of a new case, review of the literature].
J Chir (Paris). 1989 Jun-Jul;126(6-7):388-91.
10
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.腹膜间皮瘤的当前治疗选择与生物学:美国国立卫生研究院首次腹膜间皮瘤会议会议纪要
Ann Oncol. 2006 Nov;17(11):1615-9. doi: 10.1093/annonc/mdl060. Epub 2006 Apr 6.

引用本文的文献

1
Retrospective analysis of mesothelioma cases in a tertiary hospital in Northern Portugal (1988-2023): An epidemiological perspective.葡萄牙北部一家三级医院间皮瘤病例的回顾性分析(1988 - 2023年):流行病学视角
Porto Biomed J. 2025 Aug 5;10(4):e298. doi: 10.1097/j.pbj.0000000000000298. eCollection 2025 Sep-Oct.
2
Twice as Effective? Pressurized Intra-Thoracic Aerosol Chemotherapy: New Frontiers in Pleural Mesothelioma.效果加倍?胸腔内加压雾化化疗:胸膜间皮瘤的新前沿
Med Sci (Basel). 2025 Jun 2;13(2):72. doi: 10.3390/medsci13020072.
3
8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines.8C7:一种完全人源抗PTGFRN单克隆抗体药物偶联物,可抑制间皮瘤和小儿髓母细胞瘤细胞系的肿瘤生长。
J Cell Mol Med. 2025 Jun;29(12):e70665. doi: 10.1111/jcmm.70665.
4
Trends in Mesothelioma Mortality in the United States Between 1999 and 2020.1999年至2020年美国间皮瘤死亡率趋势
JTO Clin Res Rep. 2025 Feb 11;6(5):100804. doi: 10.1016/j.jtocrr.2025.100804. eCollection 2025 May.
5
Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma.恶性腹膜间皮瘤患者预后列线图的开发与验证
Front Oncol. 2025 Feb 28;15:1480197. doi: 10.3389/fonc.2025.1480197. eCollection 2025.
6
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).间皮瘤中的端粒与端粒酶:病理生理学、生物标志物及新兴治疗策略(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21.
7
Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma.腹膜间皮瘤患者端粒酶逆转录酶(TERT)mRNA水平与临床病理特征分析
Cancers (Basel). 2025 Jan 14;17(2):252. doi: 10.3390/cancers17020252.
8
Incidence, mortality and survival of pleural mesothelioma in Zurich between 1981 and 2019, Switzerland.1981年至2019年期间瑞士苏黎世胸膜间皮瘤的发病率、死亡率和生存率
J Thorac Dis. 2024 Dec 31;16(12):8240-8249. doi: 10.21037/jtd-24-766. Epub 2024 Dec 19.
9
Primary Peritoneal Mesothelioma Affecting the Greater Omentum That Mimicked an Omental Infarction: A Case Report.原发性腹膜间皮瘤累及大网膜并酷似网膜梗死:一例报告
Case Rep Oncol. 2024 May 30;17(1):596-601. doi: 10.1159/000538991. eCollection 2024 Jan-Dec.
10
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments.恶性胸膜和腹膜间皮瘤肿瘤免疫微环境的空间景观。
Cancer Res Commun. 2024 Aug 1;4(8):2133-2146. doi: 10.1158/2767-9764.CRC-23-0524.

本文引用的文献

1
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.一项关于腹膜切除术和腹腔内热灌注(IPHP)治疗腹膜间皮瘤患者的意大利多中心II期研究。
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):41-5.
2
Comprehensive management of diffuse malignant peritoneal mesothelioma.弥漫性恶性腹膜间皮瘤的综合管理
Eur J Surg Oncol. 2006 Aug;32(6):686-91. doi: 10.1016/j.ejso.2006.03.012. Epub 2006 Apr 18.
3
Systemic chemotherapy in the management of malignant peritoneal mesothelioma.全身化疗在恶性腹膜间皮瘤治疗中的应用
Eur J Surg Oncol. 2006 Aug;32(6):676-81. doi: 10.1016/j.ejso.2006.03.009. Epub 2006 Apr 17.
4
Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.经细胞减灭术和腹腔内热化疗治疗的腹膜间皮瘤:一项前瞻性研究的结果
Ann Surg Oncol. 2006 Mar;13(3):405-12. doi: 10.1245/ASO.2006.05.041. Epub 2006 Jan 30.
5
Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.腹膜间皮瘤以及原发性和继发性腹膜浆液性癌的免疫组织化学分析:雌激素和孕激素受体抗体具有实用价值。
Am J Clin Pathol. 2006 Jan;125(1):67-76.
6
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.细胞减灭术联合腹腔热灌注:采用封闭腹腔技术治疗209例腹膜表面恶性肿瘤的发病率和死亡率分析
Cancer. 2006 Mar 1;106(5):1144-53. doi: 10.1002/cncr.21708.
7
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.49例接受细胞减灭术和腹腔热灌注化疗的弥漫性恶性腹膜间皮瘤患者临床病理因素的预后分析
Ann Surg Oncol. 2006 Feb;13(2):229-37. doi: 10.1245/ASO.2006.03.045. Epub 2006 Jan 18.
8
Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases.具有横纹肌样特征的间皮瘤:10例病例的超微结构和免疫组织化学研究
Mod Pathol. 2006 Mar;19(3):373-83. doi: 10.1038/modpathol.3800543.
9
Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review.良性多囊性腹膜间皮瘤:家族性憩室病病例报告及文献综述
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1101-7. doi: 10.1111/j.1525-1438.2005.00198.x.
10
Update on malignant mesothelioma.恶性间皮瘤的最新进展。
Oncology (Williston Park). 2005 Sep;19(10):1301-9; discussion 1309-10, 1313-6.